Cardiovascular Disease's Impact On The Lipid Regulator Market Driver: A Major Catalyst in the Evolution of the Lipid Regulators Market in 2025

How Is the Lipid Regulators Market Projected to Grow, and What Is Its Market Size?_x000D_
The market for lipid regulators has seen robust expansion in the past few years. Its size is expected to increase from $7.29 billion in 2024 to $7.82 billion in 2025, to reach a 7.2% CAGR. The significant growth experienced in the historical period is linked to an increase in lifestyle diseases, growth in the aging population, more awareness regarding lipid regulators, higher healthcare expenditure, and more emphasis on healthcare prevention._x000D_
_x000D_
The market for lipid regulators is projected to undergo significant expansion in the forthcoming years. The market is set to rise to $10.2 billion by the year 2029, with an annual compound growth rate (CAGR) of 6.9%. This growth over the projected period is due to factors like the growing instances of cardiovascular diseases, an increase in cases of atherosclerosis as a result of aging, rising obesity numbers, and the augmenting occurrence of metabolic syndrome. Additionally, the expanding emphasis on customized healthcare also contributes to this trend. The forecast period will also witness key trends like innovations in the production of drugs, the assimilation of digital health solutions, the implementation of value-based pricing models, an escalated need for over-the-counter products, and the enhancement of patient-centric medication regimes._x000D_
_x000D_
What Key Elements Are Boosting Growth in the Lipid Regulators Market?_x000D_
The angina pectoris drug market is anticipated to expand, influenced by the rising occurrence of cardiovascular disorders. These disorders cover a wide array of issues affecting the heart and blood vessels, such as coronary artery disease, elevated blood pressure, heart failure, and stroke. Several factors contribute to the rising prevalence of cardiovascular ill-health includes an ageing demographic, unhealthy lifestyles, and the surge in obesity. With high cholesterol fuelling atherosclerosis - a condition where arteries narrow and harden due to a build-up of plaque - lipid regulators are integral to hampering its advance, thereby lessening the risk of strokes and heart attacks. For instance, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated that approximately 7.6 million individuals in the UK were dealing with heart and circulatory diseases as of September 2024. This includes around 4 million males and 3.6 million females. These illnesses account for about 27% of all deaths in the UK, equating to over 170,000 deaths per year, or approximately 480 deaths per day. In other words, one person dies every three minutes. Consequently, the escalating incidence of cardiovascular disorders is propelling the angina pectoris drug market's growth._x000D_
_x000D_
Get Your Free Sample Now - Explore Exclusive Market Insights:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=15848&type=smp_x000D_
_x000D_
Who Are the Major Industry Players Fueling Lipid Regulators Market Expansion?_x000D_
Major companies operating in the lipid regulators market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Amgen Inc., Merck KGaA, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Limited, Dr. Reddy's Laboratories Ltd., Biocon Ltd., Alnylam Pharmaceuticals Inc., Amarin Corporation plc, Arrowhead Pharmaceuticals Inc., Kowa Pharmaceuticals America Inc., Esperion Therapeutics Inc., Bentley Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Andrx Corporation_x000D_
_x000D_
Which Key Developments Are Influencing the Lipid Regulators Market?_x000D_
Leading entities in the lipid regulator market are spearheading the development of cutting-edge oral lipid-lowering medication to aid in the control of high low-density lipoprotein (LDL) cholesterol in patients suffering from heart ailments. These oral lipid-reducing drugs are targeted at individuals who have inherited genetic traits leading to high cholesterol levels or those who have manifested heart disease. A case in point, in May 2022, Sun Pharmaceutical Industries Limited, a generic specialty pharmaceutical firm from India, unveiled Bempedoic Acid Brillo in India, which is an orally administered drug. Brillo stands as a novel therapeutic solution for patients burdened with high LDL cholesterol and coexisting cardiac issues. Bempedoic acid works twofold - it hampers ATP citrate lyase, an enzyme crucial for cholesterol production, and triggers AMP-activated protein kinase (AMPK), which oversees cholesterol creation in the liver. The simple fact that bempedoic acid can be taken orally once a day renders it a more user-friendly choice compared to some other cholesterol-reducing medications._x000D_
_x000D_
How Is the Segmentation of the Lipid Regulators Market Defined?_x000D_
The lipid regulators market covered in this report is segmented -_x000D_
_x000D_
1) By Type: Lipid Regulators, Narcotic Analgesics, Angiotensin Converting Enzyme (ACE) Inhibitors, Respiratory Agents, Diuretics, Calcium Antagonists, Hormonal Contraceptives, Other Types_x000D_
2) By Indication: Hypercholesterolemia, Hypertriglyceridemia, Coronary Artery Disease, Other Indications_x000D_
3) By Administration: Oral, Injectable_x000D_
4) By Application: Pharmaceuticals, Vaccines And Drugs, Scientific Research, Nutrition And Supplements, Food And Beverages, Other Applications_x000D_
_x000D_
Subsegments:_x000D_
1) By Lipid Regulators: Statins, Fibrates, Niacin, Omega-3 Fatty Acids_x000D_
2) By Narcotic Analgesics: Opioid Analgesics, Combination Analgesics (Opioid And Non-opioid), Antagonists For Pain Relief_x000D_
3) By Angiotensin Converting Enzyme (ACE) Inhibitors: Captopril, Enalapril, Lisinopril, Ramipril_x000D_
4) By Respiratory Agents: Bronchodilators, Corticosteroids, Antihistamines_x000D_
5) By Diuretics: Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics_x000D_
6) By Calcium Antagonists: Dihydropyridines, Non-Dihydropyridines_x000D_
7) By Hormonal Contraceptives: Oral Contraceptives, Injectable Contraceptives, Implantable Contraceptives_x000D_
8) By Other Types: Beta Blockers, Anticoagulants, Antiplatelets_x000D_
_x000D_
Pre-Book Your Report Now For A Swift Delivery:_x000D_
https://www.thebusinessresearchcompany.com/report/lipid-regulators-global-market-report_x000D_
_x000D_
What Is the Leading Region in the Lipid Regulators Market?_x000D_
North America was the largest region in the lipid regulators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lipid regulators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_
_x000D_
What Is Covered In The Lipid Regulators Global Market Report?_x000D_
_x000D_
- Market Size Analysis: Analyze the Lipid Regulators Market size by key regions, countries, product types, and applications._x000D_
- Market Segmentation Analysis: Identify various subsegments within the Lipid Regulators Market for effective categorization._x000D_
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape._x000D_
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market._x000D_
- Market Contribution: Evaluate contributions of different segments to the overall Lipid Regulators Market growth._x000D_
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers._x000D_
- Industry Challenges: Analyze challenges and risks affecting the Lipid Regulators Market._x000D_
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market._x000D_
_x000D_
Unlock Exclusive Market Insights - Purchase Your Research Report Now!_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15848_x000D_
_x000D_

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.